China’s healthcare expenditures are increasing, with the imbalance between social health insurance revenues and expenditures continuing to intensify. This article investigates the transition from the currently mainstream fee-for-service model to the diagnosis-related group (DRG) payment model, the history of DRG in foreign markets, and the potential challenges to having a DRG payment model in China’s system.
Medical Payment Series: The rise of the DRG payment model
ByGuanjun Jiang, and Qiuwen Peng
15 May 2019
Medical Payment Series: The rise of the DRG payment model
Download the PDF